Today is the last day to apply for ipo of Sopan Pharmaceuticals. The company began selling its shares to the general public on April 16th.
The company received permission to issue shares worth 25 percent of its capital of Rs 1.71 billion. Consequently, it will sell 4,290,000 shares worth Rs 429 million to the general public.
Among all the units that have been approved, the company has already allotted 429,000 units for stocks worth Rs 42.9 million to foreign migrant workers. In addition to this, the company acquired 214,500 units for mutual funds and 171,600 units for the employees.
In this second stage, the company will allot 3,474,900 units to the public.
Minimum investment by interested investors is set to 10 shares, while the maximum number of shares is set to 11,000.
The issue manager of the company is NMB Capital. Interested investors can apply from all C-ASBA-enabled BFIs and Meroshare.
A rating is given by Care Ratings Nepal for the company, indicating the high risk level of the issuer.
Stay tuned to NepseTalk for the latest news.
लोड हुँदैछ...
0 Comments